Published in Genome Biol Evol on January 01, 2013
Characterization of MazF-Mediated Sequence-Specific RNA Cleavage in Pseudomonas putida Using Massive Parallel Sequencing. PLoS One (2016) 0.80
AAU-Specific RNA Cleavage Mediated by MazF Toxin Endoribonuclease Conserved in Nitrosomonas europaea. Toxins (Basel) (2016) 0.79
Characterization of a Deinococcus radiodurans MazF: A UACA-specific RNA endoribonuclease. Microbiologyopen (2017) 0.75
Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res (1997) 665.31
MUSCLE: multiple sequence alignment with high accuracy and high throughput. Nucleic Acids Res (2004) 168.89
Protein structure prediction on the Web: a case study using the Phyre server. Nat Protoc (2009) 32.64
Application of phylogenetic networks in evolutionary studies. Mol Biol Evol (2005) 31.72
MEME SUITE: tools for motif discovery and searching. Nucleic Acids Res (2009) 23.27
Lateral gene transfer and the nature of bacterial innovation. Nature (2000) 20.98
ProtTest: selection of best-fit models of protein evolution. Bioinformatics (2005) 19.16
Phylogeny.fr: robust phylogenetic analysis for the non-specialist. Nucleic Acids Res (2008) 19.09
CDD: a Conserved Domain Database for the functional annotation of proteins. Nucleic Acids Res (2010) 19.07
Conjugation and genetic recombination in Escherichia coli K-12. Cold Spring Harb Symp Quant Biol (1956) 9.65
Prokaryotic toxin-antitoxin stress response loci. Nat Rev Microbiol (2005) 9.08
BioProspector: discovering conserved DNA motifs in upstream regulatory regions of co-expressed genes. Pac Symp Biocomput (2001) 8.65
Neighbor-net: an agglomerative method for the construction of phylogenetic networks. Mol Biol Evol (2003) 8.51
Parallel Metropolis coupled Markov chain Monte Carlo for Bayesian phylogenetic inference. Bioinformatics (2004) 6.88
Toxin-antitoxin loci are highly abundant in free-living but lost from host-associated prokaryotes. Nucleic Acids Res (2005) 6.61
Horizontal gene transfer, genome innovation and evolution. Nat Rev Microbiol (2005) 5.21
Genomics of bacteria and archaea: the emerging dynamic view of the prokaryotic world. Nucleic Acids Res (2008) 4.78
PATRIC: the comprehensive bacterial bioinformatics resource with a focus on human pathogenic species. Infect Immun (2011) 4.57
MicrobesOnline: an integrated portal for comparative and functional genomics. Nucleic Acids Res (2009) 4.32
Discovering sequence motifs with arbitrary insertions and deletions. PLoS Comput Biol (2008) 4.10
The many faces of the helix-turn-helix domain: transcription regulation and beyond. FEMS Microbiol Rev (2005) 3.87
Crystal structure of the MazE/MazF complex: molecular bases of antidote-toxin recognition. Mol Cell (2003) 3.66
Bacterial persistence by RNA endonucleases. Proc Natl Acad Sci U S A (2011) 3.52
DOOR: a database for prokaryotic operons. Nucleic Acids Res (2008) 3.50
Comprehensive comparative-genomic analysis of type 2 toxin-antitoxin systems and related mobile stress response systems in prokaryotes. Biol Direct (2009) 3.17
Comprehensive functional analysis of Mycobacterium tuberculosis toxin-antitoxin systems: implications for pathogenesis, stress responses, and evolution. PLoS Genet (2009) 2.89
STRAP: editor for STRuctural Alignments of Proteins. Bioinformatics (2001) 2.89
New connections in the prokaryotic toxin-antitoxin network: relationship with the eukaryotic nonsense-mediated RNA decay system. Genome Biol (2003) 2.77
Molecular mechanisms of HipA-mediated multidrug tolerance and its neutralization by HipB. Science (2009) 2.74
MazF, an mRNA interferase, mediates programmed cell death during multicellular Myxococcus development. Cell (2008) 2.70
Axe-Txe, a broad-spectrum proteic toxin-antitoxin system specified by a multidrug-resistant, clinical isolate of Enterococcus faecium. Mol Microbiol (2003) 2.58
Bacterial persistence and toxin-antitoxin loci. Annu Rev Microbiol (2012) 2.28
Diversity of bacterial type II toxin-antitoxin systems: a comprehensive search and functional analysis of novel families. Nucleic Acids Res (2011) 2.19
Toxin-antitoxin systems: why so many, what for? Curr Opin Microbiol (2010) 2.02
Molecular epidemiology of methicillin-resistant Staphylococcus aureus. Emerg Infect Dis (2001) 1.97
The Escherichia coli extracellular death factor EDF induces the endoribonucleolytic activities of the toxins MazF and ChpBK. Mol Cell (2011) 1.96
Toxins-antitoxins: diversity, evolution and function. Crit Rev Biochem Mol Biol (2011) 1.74
Plasmid copy-number control and better-than-random segregation genes of pSM19035 share a common regulator. Proc Natl Acad Sci U S A (2000) 1.73
Structure of FitAB from Neisseria gonorrhoeae bound to DNA reveals a tetramer of toxin-antitoxin heterodimers containing pin domains and ribbon-helix-helix motifs. J Biol Chem (2006) 1.71
A new type V toxin-antitoxin system where mRNA for toxin GhoT is cleaved by antitoxin GhoS. Nat Chem Biol (2012) 1.67
The structure of plasmid-encoded transcriptional repressor CopG unliganded and bound to its operator. EMBO J (1998) 1.64
Doc of prophage P1 is inhibited by its antitoxin partner Phd through fold complementation. J Biol Chem (2008) 1.62
Evolution of mosaic operons by horizontal gene transfer and gene displacement in situ. Genome Biol (2003) 1.62
prlF and yhaV encode a new toxin-antitoxin system in Escherichia coli. J Mol Biol (2007) 1.57
Characterization of MazFSa, an endoribonuclease from Staphylococcus aureus. J Bacteriol (2007) 1.47
AbrB-like transcription factors assume a swapped hairpin fold that is evolutionarily related to double-psi beta barrels. Structure (2005) 1.45
Methicillin resistant Staphylococcus aureus (MRSA) in the intensive care unit. Postgrad Med J (2002) 1.43
Evolution of a protein fold in vitro. Science (1999) 1.42
ProOpDB: Prokaryotic Operon DataBase. Nucleic Acids Res (2011) 1.40
The regulation of the Escherichia coli mazEF promoter involves an unusual alternating palindrome. J Biol Chem (2000) 1.37
Staphylococcus aureus: a community pathogen. Infect Dis Clin North Am (2009) 1.37
Structural basis for nucleic acid and toxin recognition of the bacterial antitoxin CcdA. J Mol Biol (2006) 1.32
NikR-operator complex structure and the mechanism of repressor activation by metal ions. Proc Natl Acad Sci U S A (2006) 1.26
The Bacillus subtilis ydcDE operon encodes an endoribonuclease of the MazF/PemK family and its inhibitor. Mol Microbiol (2005) 1.26
Structural mechanism of transcriptional autorepression of the Escherichia coli RelB/RelE antitoxin/toxin module. J Mol Biol (2008) 1.26
New toxins homologous to ParE belonging to three-component toxin-antitoxin systems in Escherichia coli O157:H7. Mol Microbiol (2010) 1.25
Bacterial persistence: some new insights into an old phenomenon. J Biosci (2008) 1.25
Interaction specificity, toxicity and regulation of a paralogous set of ParE/RelE-family toxin-antitoxin systems. Mol Microbiol (2010) 1.24
Functional interactions between coexisting toxin-antitoxin systems of the ccd family in Escherichia coli O157:H7. J Bacteriol (2007) 1.22
Balancing at survival's edge: the structure and adaptive benefits of prokaryotic toxin-antitoxin partners. Curr Opin Struct Biol (2011) 1.20
Structural biology and drug discovery for protein-protein interactions. Trends Pharmacol Sci (2012) 1.15
Artificial activation of toxin-antitoxin systems as an antibacterial strategy. Trends Microbiol (2012) 1.15
The yefM-yoeB toxin-antitoxin systems of Escherichia coli and Streptococcus pneumoniae: functional and structural correlation. J Bacteriol (2006) 1.12
Bacterial toxin-antitoxin systems: Translation inhibitors everywhere. Mob Genet Elements (2011) 1.11
Noncognate Mycobacterium tuberculosis toxin-antitoxins can physically and functionally interact. J Biol Chem (2010) 1.11
Structure of the Escherichia coli antitoxin MqsA (YgiT/b3021) bound to its gene promoter reveals extensive domain rearrangements and the specificity of transcriptional regulation. J Biol Chem (2010) 1.11
Characterization of dual substrate binding sites in the homodimeric structure of Escherichia coli mRNA interferase MazF. J Mol Biol (2005) 1.10
Modular organization of the Phd repressor/antitoxin protein. J Bacteriol (2004) 1.09
Automated discovery and phylogenetic analysis of new toxin-antitoxin systems. BMC Microbiol (2008) 1.08
The decay of the chromosomally encoded ccdO157 toxin-antitoxin system in the Escherichia coli species. Genetics (2009) 1.08
Functional interactions between chpB and parD, two homologous conditional killer systems found in the Escherichia coli chromosome and in plasmid R1. FEMS Microbiol Lett (1998) 1.07
Genomic insights into the contribution of phytopathogenic bacterial plasmids to the evolutionary history of their hosts. Annu Rev Phytopathol (2007) 1.02
Insights into the nature of DNA binding of AbrB-like transcription factors. Structure (2008) 1.01
Is methicillin-resistant Staphylococcus aureus an emerging community pathogen? A review of the literature. Can J Infect Dis (2000) 0.99
A toxin-antitoxin module as a target for antimicrobial development. Plasmid (2009) 0.98
Structure and function of bacterial kid-kis and related toxin-antitoxin systems. Protein Pept Lett (2007) 0.96
PemK toxin of Bacillus anthracis is a ribonuclease: an insight into its active site, structure, and function. J Biol Chem (2009) 0.94
Genetic identification of two functional regions in the antitoxin of the parD killer system of plasmid R1. FEMS Microbiol Lett (2002) 0.93
Interactions of Kid-Kis toxin-antitoxin complexes with the parD operator-promoter region of plasmid R1 are piloted by the Kis antitoxin and tuned by the stoichiometry of Kid-Kis oligomers. Nucleic Acids Res (2007) 0.91
The role of prophage for genome diversification within a clonal lineage of Lactobacillus johnsonii: characterization of the defective prophage LJ771. J Bacteriol (2008) 0.91
Modeling of the structure and interactions of the B. anthracis antitoxin, MoxX: deletion mutant studies highlight its modular structure and repressor function. J Comput Aided Mol Des (2011) 0.90
Structural features of the plasmid pMV158-encoded transcriptional repressor CopG, a protein sharing similarities with both helix-turn-helix and beta-sheet DNA binding proteins. Proteins (1998) 0.87
Interactions between the toxin Kid of the bacterial parD system and the antitoxins Kis and MazE. Proteins (2007) 0.87
Crystal structure of YdcE protein from Bacillus subtilis. Proteins (2003) 0.86
Novel quorum-sensing peptides mediating interspecies bacterial cell death. MBio (2013) 0.82
Modulating protein-protein interactions with small molecules: the importance of binding hotspots. J Mol Biol (2011) 0.80
A common origin for the bacterial toxin-antitoxin systems parD and ccd, suggested by analyses of toxin/target and toxin/antitoxin interactions. PLoS One (2012) 0.80
Treatment of acute otitis media in children under 2 years of age. N Engl J Med (2011) 10.39
Risk of renal scarring in children with a first urinary tract infection: a systematic review. Pediatrics (2010) 3.01
Identification of MMP-1 as a putative breast cancer predictive marker by global gene expression analysis. Nat Med (2005) 1.81
The adenylate cyclase toxins. Crit Rev Microbiol (2004) 1.33
alpha-Enolase binds to human plasminogen on the surface of Bacillus anthracis. Biochim Biophys Acta (2008) 1.17
Bacterial insecticidal toxins. Crit Rev Microbiol (2004) 1.08
Factors that influence parental decisions to participate in clinical research: consenters vs nonconsenters. JAMA Pediatr (2013) 1.07
Anthrax edema toxin requires influx of calcium for inducing cyclic AMP toxicity in target cells. Infect Immun (2002) 1.05
Estrogen receptors beta4 and beta5 are full length functionally distinct ERbeta isoforms: cloning from human ovary and functional characterization. Endocrine (2005) 1.01
Intradermal immunization with outer membrane protein 25 protects Balb/c mice from virulent B. abortus 544. Mol Immunol (2012) 0.95
PemK toxin of Bacillus anthracis is a ribonuclease: an insight into its active site, structure, and function. J Biol Chem (2009) 0.94
Expression of carcinoembryonic antigen cell adhesion molecule 6 oncoprotein in atypical ductal hyperplastic tissues is associated with the development of invasive breast cancer. Clin Cancer Res (2006) 0.92
Identification and characterization of a novel toxin-antitoxin module from Bacillus anthracis. FEBS Lett (2007) 0.91
GroEL provides protection against Bacillus anthracis infection in BALB/c mice. Mol Immunol (2010) 0.90
Modeling of the structure and interactions of the B. anthracis antitoxin, MoxX: deletion mutant studies highlight its modular structure and repressor function. J Comput Aided Mol Des (2011) 0.90
Surface localized and extracellular Glyceraldehyde-3-phosphate dehydrogenase of Bacillus anthracis is a plasminogen binding protein. Biochim Biophys Acta (2010) 0.89
Cell mediated immune response after challenge in Omp25 liposome immunized mice contributes to protection against virulent Brucella abortus 544. Vaccine (2012) 0.89
Emergence of Streptococcus pneumoniae serogroups 15 and 35 in nasopharyngeal cultures from young children with acute otitis media. Pediatr Infect Dis J (2014) 0.89
An insecticidal GroEL protein with chitin binding activity from Xenorhabdus nematophila. J Biol Chem (2008) 0.88
Gln277 and Phe554 residues are involved in thermal inactivation of protective antigen of Bacillus anthracis. Biochem Biophys Res Commun (2002) 0.87
Catalytically inactive anthrax toxin(s) are potential prophylactic agents. Vaccine (2007) 0.87
Inhibition of anthrax toxins with a bispecific monoclonal antibody that cross reacts with edema factor as well as lethal factor of Bacillus anthracis. Mol Immunol (2011) 0.86
Identification of amino acid residues of anthrax protective antigen involved in binding with lethal factor. Infect Immun (2002) 0.86
Thermal inactivation of protective antigen of Bacillus anthracis and its prevention by polyol osmolytes. Biochem Biophys Res Commun (2004) 0.86
Anthrax vaccines: present status and future prospects. Expert Rev Vaccines (2013) 0.85
Oral vaccines: new needs, new possibilities. Bioessays (2007) 0.85
Inhibition of platelet aggregation by anthrax edema toxin. Biochem Biophys Res Commun (2005) 0.85
Rabies vaccines: where do we stand, where are we heading? Expert Rev Vaccines (2014) 0.85
Identification and characterization of immunodominant B-cell epitope of the C-terminus of protective antigen of Bacillus anthracis. Mol Immunol (2009) 0.85
Characterization of a cytotoxic pilin subunit of Xenorhabdus nematophila. Biochem Biophys Res Commun (2004) 0.85
A single-dose PLGA encapsulated protective antigen domain 4 nanoformulation protects mice against Bacillus anthracis spore challenge. PLoS One (2013) 0.84
A plant based protective antigen [PA(dIV)] vaccine expressed in chloroplasts demonstrates protective immunity in mice against anthrax. Vaccine (2011) 0.83
Rabies DNA vaccine encoding lysosome-targeted glycoprotein supplemented with Emulsigen-D confers complete protection in preexposure and postexposure studies in BALB/c mice. FASEB J (2009) 0.83
Rabies DNA vaccine: no impact of MHC class I and class II targeting sequences on immune response and protection against lethal challenge. Vaccine (2009) 0.82
Expression of protective antigen in transgenic plants: a step towards edible vaccine against anthrax. Biochem Biophys Res Commun (2002) 0.82
Cloning and expression of mycobacterial glutamine synthetase gene in Escherichia coli. Biochem Biophys Res Commun (2004) 0.81
Efficacy of recombinant anthrax vaccine against Bacillus anthracis aerosol spore challenge: preclinical evaluation in rabbits and Rhesus monkeys. Biotechnol J (2009) 0.81
Kinetic characterization and ligand binding studies of His351 mutants of Bacillus anthracis adenylate cyclase. Arch Biochem Biophys (2005) 0.81
Enzymatic characterization of Catalase from Bacillus anthracis and prediction of critical residues using information theoretic measure of Relative Entropy. Biochem Biophys Res Commun (2011) 0.80
Integrative analysis of ocular complications in atherosclerosis unveils pathway convergence and crosstalk. J Recept Signal Transduct Res (2014) 0.78
Biochemical characterization of alanine racemase--a spore protein produced by Bacillus anthracis. BMB Rep (2009) 0.78
Anthrax protective antigen administered by DNA vaccination to distinct subcellular locations potentiates humoral and cellular immune responses. Eur J Immunol (2009) 0.77
The osmoprotectants glycine and its methyl derivatives prevent the thermal inactivation of protective antigen of Bacillus anthracis. Biochem Biophys Res Commun (2004) 0.77
Structure-based design of a novel peptide inhibitor of HIV-1 integrase: a computer modeling approach. J Biomol Struct Dyn (2002) 0.77
Deletion mutants of protective antigen that inhibit anthrax toxin both in vitro and in vivo. Biochem Biophys Res Commun (2003) 0.77
Mechanisms underlying the opposing effects of P2Y receptors on the cell cycle. J Recept Signal Transduct Res (2008) 0.77
Recent progress in the development of anthrax vaccines. Recent Pat Biotechnol (2011) 0.77
Recombinant GroEL enhances protective antigen-mediated protection against Bacillus anthracis spore challenge. Med Microbiol Immunol (2012) 0.76
S-layer homology motif is an immunogen and confers protection to mouse model against anthrax. Mol Immunol (2011) 0.76
Structural basis of Bacillus anthracis MoxXT disruption and the modulation of MoxT ribonuclease activity by rationally designed peptides. J Biomol Struct Dyn (2014) 0.76
Evaluation of the ability of N-terminal fragment of lethal factor of Bacillus anthracis for delivery of Mycobacterium T cell antigen ESAT-6 into cytosol of antigen presenting cells to elicit effective cytotoxic T lymphocyte response. Biochem Biophys Res Commun (2006) 0.76
Cloning, expression, and characterization of recombinant nitric oxide synthase-like protein from Bacillus anthracis. Biochem Biophys Res Commun (2005) 0.75
Poly-L-glutamate/glutamine synthesis in the cell wall of Mycobacterium bovis is regulated in response to nitrogen availability. BMC Microbiol (2013) 0.75
Asp 187 and Phe 190 residues in lethal factor are required for the expression of anthrax lethal toxin activity. FEMS Microbiol Lett (2002) 0.75
A coalition of the film industry and public health leaders. Pediatrics (2008) 0.75
Erratum: Newly identified motifs in Candida albicans Cdr1 protein nucleotide binding domains are pleiotropic drug resistance subfamily-specific and functionally asymmetric. Sci Rep (2016) 0.75
Transformation of an edible crop with the pagA gene of Bacillus anthracis. FASEB J (2005) 0.75
Expression of anthrax lethal factor gene by osmolyte induction. FEMS Microbiol Lett (2002) 0.75
Genetic immunization with GPI-anchored anthrax protective antigen raises combined CD1d- and MHC II-restricted antibody responses by natural killer T cell-mediated help. Vaccine (2009) 0.75
In silico structure-based design of a potent, mutation resilient, small peptide inhibitor of HIV-1 reverse transcriptase. J Biomol Struct Dyn (2003) 0.75
Induction of cytotoxic T lymphocyte response against Mycobacterial antigen using domain I of anthrax edema factor as antigen delivery system. Biochem Biophys Res Commun (2007) 0.75
Positive selection and evolution of dengue type-3 virus in the Indian subcontinent. J Vector Borne Dis (2013) 0.75